Press release
Stocks to Watch for Short Squeeze Potential: DJT, INBS, IMPP, HUBC, XXII
Investors must stay alert to stocks poised for a short squeeze, given the significant gains typically seen during such events. Here's a glimpse into five stocks potentially set for a short squeeze surge in the future.Trump Media & Technology Corp. (NASDAQ: DJT) witnessed a stellar debut last week, followed by a more subdued performance. The short interest in DJT stock, reflecting borrowed shares anticipating a price drop, hit 4.93 million, representing 12.6% of available shares. Notably, the borrowing rate spiked to 500% due to limited shortable shares, hinting at potential short covering and a share price uptick in the future.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is attracting attention this week for potential short squeeze dynamics. As a leading provider of innovative medical tech, it posted impressive financials for Q2 and the six months ending Dec 31, 2023, with a 114% revenue increase YoY for Q2 and 337% for the six months. This growth is tied to its Intelligent Fingerprinting Drug Screening System and global expansion. The stock hit an intraday high of $11.70 and closing high of $6.76 in 2024. This low-float stock is currently oversold, and the short interest in INBS stock surged to 57.64% in the latest report is adding intrigue to INBS's stock movement.
Imperial Petroleum Inc. (NASDAQ: IMPP) is worth monitoring due to its significant short interest. On February 13, IMPP announced its financial results for the fourth quarter and fiscal year ending December 31, 2023. The company's revenues for the quarter were $29.9 million, down from $37.9 million in the previous year, while net income decreased from $13.8 million to $6.5 million. However, for the full fiscal year, revenues rose by $86.7 million to reach $183.7 million compared to the previous year.
HUB Cyber Security Ltd. (NASDAQ: HUBC) is a potential stock to watch this week, given its focus on confidential computer cyber security solutions and services. On April 5, HUBC made headlines by securing $8 million in new financing through a straight debt arrangement. This strategic financing is aimed at bolstering the company's financial position and enhancing its future prospects, as stated in the news release.
22nd Century Group Inc. (NASDAQ: XXII), a company focused on reducing nicotine harm in tobacco products, disclosed its financial performance for the quarter ending December 31, 2023, on March 28. The company reported a decrease in net revenues from $10 million to $7.4 million compared to the prior-year period. The operating loss widened from $10.2 million to $14.2 million year-over-year. Despite this, the gross profit surged from $0.1 million to $7.8 million in the same period.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=stocks-to-watch-for-short-squeeze-potential-djt-inbs-impp-hubc-xxii]
Country: United States
Website: http://www.thestreetreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stocks to Watch for Short Squeeze Potential: DJT, INBS, IMPP, HUBC, XXII here
News-ID: 3459246 • Views: …
More Releases from ABNewswire
AI Magazine Netherlands names IntraGPT most secure and best local AI LLM
Dutch local AI platform sets new benchmark for safe enterprise AI and data privacy. IntraGPT, a local AI platform based in the Netherlands, has been named the most secure, safe and best local AI large language model platform by AI Magazine Netherlands. The recognition highlights how fast local AI is becoming the preferred choice for organisations that want powerful AI with full control over their data.
IntraGPT, a local AI platform…
QuoteIQ Expands Enterprise Capabilities: From Solo Startups to Unlimited-User Te …
Leading Contractor-Built CRM Platform Delivers Scalable Solutions for Home Service Businesses of Every Size
SAVANNAH, GA - December 22, 2025 - QuoteIQ, the comprehensive CRM platform built by contractors for contractors, continues to demonstrate its commitment to serving home service businesses at every stage of growth, from solo operators launching their first venture to established enterprises managing unlimited users across multiple crews and locations.
With over 40,000 active users across industries including…
Where Culture Meets the Court: Igor Brisa on Playing Futsal for Justin Bieber's …
In the evolving landscape where fashion, music, and sport overlap, futsal has quietly become a language of culture. Fast, expressive, and demanding, the game mirrors the rhythm of modern creative communities, and that is exactly where SKYLRK, Justin Bieber's lifestyle brand, finds its footing.
Image: https://www.abnewswire.com/upload/2025/12/4b80d6d4c42d57b2d6ee33210ba7dca7.jpg
Recently, entrepreneur and lifelong footballer Igor Brisa took to the futsal court representing SKYLRK at The League by Surgeon, one of Los Angeles' most respected futsal…
Why Businesses Should Start the New Year by Talking to Consultant Georg Meyer
Georg Meyer explains the importance of a clear and proper strategy as we enter the New Year.
As companies set priorities for the year ahead, consultant and systems strategist Georg Meyer [https://georgmeyer.ch/] believes the start of the year is the most important moment for leaders to step back, reassess, and make intentional choices about where their business is heading.
"Refocus on the essential," Meyer advises. "Just as many of us do it…
More Releases for INBS
"Stocks to Watch Showing Strong Market Potential INBS, NANO.T, MLGO, KAVL, PNPN. …
As investors seek opportunities in a dynamic market, several key stocks-Intelligent Bio Solutions, Nano One, Power Nickel, MicroAlgo, and Kaival Brands-are demonstrating significant growth potential driven by strategic initiatives and sector innovations.
Intelligent Bio Solutions (NASDAQ: INBS): INBS has announced a 64% YoY increase in preliminary Q4 revenue and is trading up on heavy volume, reaching $3 in early trading. The stock is challenging its 200-day moving average of $2.93, and…
"Game-Changing Biotech Companies Making Waves: INBS, PMVP, TPST, OMGA, MRSN"
In the rapidly evolving biotech sector, a few standout companies are pushing boundaries and setting new standards. From Intelligent Bio Solutions' innovative drug testing technology to PMV Pharmaceuticals' promising clinical trial advancements, these trailblazers are not just making headlines-they're shaping the future of healthcare while improving the workplace. Discover how these five companies are leading the charge in innovation, with significant developments that could impact industries and lives worldwide.
Intelligent Bio…
Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL
Investors frequently search for stocks of companies with improving operational performance. This article offers an in-depth look at five companies that have recently made significant progress.
NKGen Biotech Inc. (NASDAQ: NKGN): A clinical-stage biotech firm, NKGen Biotech is focused on developing and commercializing allogeneic, autologous, and CAR-NK natural killer cell therapies. On May 20, the company announced that its cryopreserved autologous, enhanced, and expanded SNK01 had received clearance from the Safety…
Intelligent Bio Solutions Inc. (NASDAQ: INBS): Research Report Update May 2024
Intelligent Bio Solutions Inc. (NASDAQ: INBS) remains on track to enter the U.S. market in 2025. Sales momentum at Intelligent Bio Solutions remained strong, with the addition of 26 new accounts in the first fiscal quarter. These new accounts included 16,779 employees. Another key aspect is that Intelligent Bio Solutions continues to enhance its intellectual property portfolio. Recently, its DSR-PLUS Cartridge Reader received a European patent for unitary use. See…
Market Movers on The Street: LAZR, INBS, REBN, PSRO
Luminar Technologies (NASDAQ: LAZR) The company, which manufactures lidar sensors meant for self-driving cars, was in focus on May 8 following a key announcement. Luminar Technologies revealed that in the first fiscal quarter, Tesla was its biggest customer and made up 10% of its revenues of $21 million for the quarter. It was a significant announcement since Tesla Chief Executive Officer Elon Musk is fully committed to the success of…
Discovering Undervalued Stocks in Today's Market: OCGN, INBS, KAVL, DYAI, VTAK
Ocugen Inc (NASDAQ:OCGN) stock has been moving higher over the past week. This morning, the company announced that Benjamin Bakall, MD, PhD, Director of Clinical Research at Associated Retina Consultants and Clinical Assistant Professor at the University of Arizona, College of Medicine-Phoenix will present data from the OCU400 Phase 1/2 clinical trial at the Retinal Cell and Gene Therapy Innovation Summit being held May 3, 2024 in Seattle, WA.
Intelligent Bio…
